SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001600132-19-000170
Filing Date
2019-12-27
Accepted
2019-12-27 08:25:35
Documents
4
Period of Report
2019-12-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A blphproxydecember2019.htm PRE 14A 231969
2 a035yzbbellerophontherape01.jpg GRAPHIC 315431
3 a035yzbbellerophontherapeuti.jpg GRAPHIC 757673
4 blphlogoa65.jpg GRAPHIC 32979
  Complete submission text file 0001600132-19-000170.txt   1756782
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36845 | Film No.: 191311726
SIC: 2834 Pharmaceutical Preparations